- June 2021, Laboratory testing has confirmed that casirivimab and imdevimab
are able to neutralize these clinical variants of Covid-19.
Efficacy of MAbs Against SARS-CoV-2 Variants
top of page
Clean. Cover. Clear. Continue Testing. Consider the Vaccine.
Educating Communities and Businesses During a Global Pandemic
bottom of page